Shukra Pharmaceuticals Ltd.

BSE: 524632 |

Shukra Pharma Live Share Price Today, Share Analysis and Chart

Mid-range Performer

Iran war impact

The impact of the ongoing Iran-Israel conflict and the broader regional instability on Shukra Pharmaceuticals Ltd. (RELISH) is assessed as minimal based on the company's current operational structure and geographical footprint as of early 202...

33.06 -0.99 (-2.91%)

49.34% Fall from 52W High

307.0K

BSE Volume

BSE 25 Mar, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Neutral

42.3 / 100

Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM

No estimates available

Shukra Pharma Live Price Chart

Loading Fundamental data..

Loading data..

Is Shukra Pharmaceuticals Ltd. worth buying?

62 Votes:

Buy 74.19%

Sell 14.52%

Hold 11.29%